Sangamo Therapeutics
SGMO
#9831
Rank
โ‚ฌ52.17 M
Marketcap
0,13ย โ‚ฌ
Share price
-2.01%
Change (1 day)
-71.57%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚ฌ52.17 Million

As of May 2026 Sangamo Therapeutics has a market cap of โ‚ฌ52.17 Million. This makes Sangamo Therapeutics the world's 9831th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ52.17 M-57.14%
2025โ‚ฌ0.12 B-76.28%
2024โ‚ฌ0.51 B488.9%
2023โ‚ฌ87.16 M-81.83%
2022โ‚ฌ0.47 B-50.27%
2021โ‚ฌ0.96 B-46.24%
2020โ‚ฌ1.79 B107.09%
2019โ‚ฌ0.86 B-15.5%
2018โ‚ฌ1.02 B-11.24%
2017โ‚ฌ1.15 B464.13%
2016โ‚ฌ0.20 B-65.14%
2015โ‚ฌ0.58 B-31.98%
2014โ‚ฌ0.86 B37.96%
2013โ‚ฌ0.62 B159.69%
2012โ‚ฌ0.24 B110.08%
2011โ‚ฌ0.11 B-49.34%
2010โ‚ฌ0.22 B21.84%
2009โ‚ฌ0.18 B82.26%
2008โ‚ฌ0.10 B-71.63%
2007โ‚ฌ0.35 B105.1%
2006โ‚ฌ0.17 B68.55%
2005โ‚ฌ0.10 B-6.96%
2004โ‚ฌ0.11 B3.1%
2003โ‚ฌ0.10 B52.19%
2002โ‚ฌ71.23 M-72.49%
2001โ‚ฌ0.25 B-43.52%
2000โ‚ฌ0.45 B

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Sangamo Therapeutics was reported to be:

โ‚ฌ45.59 Million
by Nasdaq info icon info icon
โ‚ฌ53.24 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ477.87 B 915,806.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ154.12 B 295,298.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ23.95 B 45,812.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ22.53 B 43,094.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ139.22 B 266,744.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ241.48 B 462,740.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ33.83 B 64,745.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ8.31 B 15,831.24%๐Ÿ‡บ๐Ÿ‡ธ USA